2 months 2 weeks ago
Continuous and flash glucose monitoring devices produce data reports (e.g. ambulatory glucose profile [AGP]) that can be used by people with diabetes and health-care providers (HCPs). Clinical benefits of these reports have been published, but the patient perspective is underreported.
Katharine Mackett, Hertzel Gerstein, Nancy Santesso
2 months 2 weeks ago
The prevalence of autoimmune thyroid disease in the type 1 diabetes (T1D) population is 15% to 49.3% (1). Consequently, the management of thyroid conditions is of relevance to those living with T1D. In Graves’ disease, management of hyperthyroidism focusses on thionamide and beta-blocker therapy; symptoms can be managed with beta blockade during early disease evaluation.
Nancy Cardinez, Abdulmohsen Bakhsh, Bruce A. Perkins
3 months ago
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a class of oral glucose-lowering agents commonly used for the treatment of type 2 diabetes. With increased use, there has been an increase in the incidence of the rare but life-threatening complication of euglycemic diabetic ketoacidosis. A common but underappreciated precipitant is colonoscopy. In this work, we outline the pathophysiology of the interaction between colonoscopy and SGLT2i use, the evidence regarding SGLT2i use in the periprocedural setting and Australian Diabetes Society guidelines.
Venkatesan Thiruvenkatarajan, Joshua M. Inglis, Emily Meyer, Mahesh M. Umapathysivam, Nagesh Nanjappa, Roelof Van Wijk, David Jesudason
3 months 1 week ago
Our aim in this study was to evaluate the impact of virtual care for gestational diabetes mellitus (GDM) in the context of the COVID-19 pandemic.
Alexa Clark, Elizabeth Jung, Cydney Prusky, Baiju R. Shah, Ilana J. Halperin
3 months 1 week ago
Psychological factors associated with diabetes (e.g. diabetes distress, comorbid mental health disorders and self-management behaviours) are recognized in the 2018 Diabetes Canada Clinical Practice Guidelines as having a significant impact on individuals’ health outcomes and lived experience with diabetes (1). As such, prevention and intervention treatments (e.g. motivational interventions, coping skills, self-efficacy enhancement, stress management and family interventions) have all been promoted in the literature to help address these psychosocial factors (1).
Jessica C. Kichler
Checked
34 minutes 11 seconds ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
